Advertisement

The effect of 5-fluorouracil on rat adrenal function

  • D. J. Kerr
  • A. D. Burt
  • G. H. Beastall
  • C. D. Holloway
Articles
  • 18 Downloads

Abstract

This study was undertaken to determine the effects of 5-fluorouracil on corticosteroidogenesis and adrenal size in the rat. The rats were injected intraperitoneally with 5-FU (12.5 mg kg−1 or 25 mg kg−1), normal saline or actinomycin D (0.02 mg kg−1), daily for 10 days. High-dose 5-FU induces adrenal hyperplasia, in association with mild impairment of corticosteroidogenesis (manifest by lower corticosterone and higher ACTH levels). The response to low-dose 5-FU and actinomycin D is of lesser adrenal hyperplasia, relative to high-dose 5-FU (P<0.05) and elevated corticosterone levels. There may be a dose-related effect on the suppression of corticosteroidogenesis in the rat by 5-FU.

Key words

5-Fluorouracil Corticosterone ACTH 

References

  1. 1.
    Cantarow A, Rupp J J, Goddard J W: Effects of 5-fluorouracil and adrenocortical hormones on tumours and adrenals in rats bearing transplanted tumours.Proc Soc Exp Biol Med 116, 1139 (1964).PubMedGoogle Scholar
  2. 2.
    Palma V: Effeto di farmoci antitumorati sulla i—pertropia compensatoria del rene e del surrere.Atti Acod Med Lomb 16, 409 (196?).Google Scholar
  3. 3.
    Kuo E Y H, Esber H J, Taylor D J, Bogden A E: Effects of cancer chemotherapeutic agents on endocrine organs and serum levels of oestroges, progesterone, prolactin and luteinising hormone.Cancer Res 35, 1975 (1975).PubMedGoogle Scholar
  4. 4.
    Staehelin M: Action of puromycin and 5-FU on the adrenal responsiveness to corticotrophin.Experimentia 21, 229 (1965).CrossRefGoogle Scholar
  5. 5.
    Ney R L, Davis W W, Gamen L D: Heterogenetics of template RNA in adrenal glands.Science 135, 896 (1966).CrossRefGoogle Scholar
  6. 6.
    Symington T:Functional Pathology of the Adrenal Gland. Baltimore, Williams & Wilkins (1969).Google Scholar
  7. 7.
    Morgan M W E, O'Hare M J: Cytotoxic drugs and the human adrenal cortex—a cell culture study.Cancer 43, 969 (1979).PubMedCrossRefGoogle Scholar
  8. 8.
    Goss G H, Umberger E J, Davis K J, Davis L J: A preliminary report on the effect of 8 carcinostatic agents on endocrine glands.Cancer Chemother Rep 3, 16 (1959).Google Scholar
  9. 9.
    Heidelberger C: fluorinated pyrimidines, in: Davidson J N (ed):Progress in Nucleic Acid Research and Molecular Biology, VD4, pp. 1–50. New York, Academic Press (1965).Google Scholar
  10. 10.
    Moore G, Meiselbaugh D: Hyperpigmentation after cancer chemotherapy.Lancet ii, 128 (1975).Google Scholar
  11. 11.
    Morrow I B, Burrow G N, Kaplan S R, Mulrow P J: Adrenal function in patients treated with testosterone and fluorinated pyrimidines.J Clin Endocr Metab 28, 308 (1968).PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1986

Authors and Affiliations

  • D. J. Kerr
    • 1
  • A. D. Burt
    • 2
  • G. H. Beastall
    • 4
  • C. D. Holloway
    • 3
  1. 1.Department of Medical OncologyGlasgow UniversityGlasgowU.K.
  2. 2.Department of PathologyWestern InfirmaryGlasgowU.K.
  3. 3.MRC Blood Pressure UnitWestern InfirmaryGlasgowU.K.
  4. 4.Department of Clinical ChemistryGlasgow Royal InfirmaryGlasgowU.K.

Personalised recommendations